Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.23B
+20.9% from 2023
Prescriptions
97K
$12,679.17 per claim
Patients
11K
2,415 prescribers
Total spending, 2024
$1.23B
$112,362.87 per patient
Medicare prescription drug plans paid $1.23B for Opsumit in 2024, for 97,115 prescriptions and refills to 10,959 patients (up 20.9% from 2023). The average cost per claim was $12,679.17.
Texas had the highest Medicare cost for Opsumit in 2024: $121.0M for 9,558 claims, followed by California ($96.8M).
Hunter C Champion Sr., cardiology in Columbus, GA, had the highest Medicare cost for Opsumit in 2024: 1,254 claims costing $15.9M.
Opsumit is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Actelion Pharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hunter C Champion Sr. Columbus, GA | Cardiology | 1,254 | 127 | $15.9M |
| John W McConnell Louisville, KY | Pulmonary Disease | 946 | 100 | $12.0M |
| Vallerie V McLaughlin |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,093 | 69,155 | 8,253 | $816.7M |
| 2023 | 2,210 | 79,536 | 9,025 | $1.02B |
| 2024 | 2,415 | 97,115 | 10,959 | $1.23B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 935 |
| 94 |
| $11.8M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 829 | 90 | $10.5M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 800 | 88 | $10.0M |
| Scarlett H Harden Dallas, TX | Nurse Practitioner | 743 | 92 | $9.3M |
| Muhammad Waqas Little Rock, AR | Advanced Heart Failure and Transplant Cardiology | 691 | 74 | $8.7M |
| Jean M Elwing Cincinnati, OH | Pulmonary Disease | 677 | 82 | $8.6M |
| Alvaro U Aranda- Rodriguez Guaynabo, PR | Pulmonary Disease | 674 | 78 | $8.5M |
| Frank Cefali New York, NY | Nurse Practitioner | 679 | 88 | $8.5M |
| Sandeep Sahay Houston, TX | Pulmonary Disease | 660 | 76 | $8.4M |
| Therese J Sargent Phoenix, AZ | Nurse Practitioner | 575 | 76 | $7.3M |
| Ashwin K Ravichandran Indianapolis, IN | Advanced Heart Failure and Transplant Cardiology | 465 | 46 | $5.9M |
| Marc R Pritzker Minneapolis, MN | Cardiology | 465 | 56 | $5.8M |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 458 | 52 | $5.7M |
| Zeenat Safdar Houston, TX | Pulmonary Disease | 445 | 48 | $5.6M |
| Hilamber Subba South Portland, ME | Internal Medicine | 444 | 48 | $5.6M |
| Thenappan Thenappan Minneapolis, MN | Advanced Heart Failure and Transplant Cardiology | 396 | 42 | $4.9M |
| Marjorie P George Denver, CO | Critical Care (Intensivists) | 381 | 38 | $4.8M |
| Naomi G Habib Phoenix, AZ | Pulmonary Disease | 377 | 43 | $4.8M |
| Lynette M Brown Blackfoot, ID | Critical Care (Intensivists) | 353 | 53 | $4.7M |
| Barry K Rayburn Birmingham, AL | Internal Medicine | 363 | 42 | $4.6M |
| John D Dallas Austin, TX | Pulmonary Disease | 352 | 34 | $4.5M |
| Kimberly C Thompson Rochester, MN | Nurse Practitioner | 351 | 44 | $4.4M |
| Robert L Scott Phoenix, AZ | Advanced Heart Failure and Transplant Cardiology | 362 | 44 | $4.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Actelion Pharma JNJ | 97,146 | $1.23B |